37 Cases of Lupus 1 Number Decoction in the Treatment of Systemic Lupus Erythematosus

WANG Fu-zu; MA Hui-zhong; ZHOU Chun-yan; XING Yuan

doi:10.11653/syfj2013230278

您当前的位置：

首页 >

文章列表页 >

37 Cases of Lupus 1 Number Decoction in the Treatment of Systemic Lupus Erythematosus

更新时间：2024-01-04

- 37 Cases of Lupus 1 Number Decoction in the Treatment of Systemic Lupus Erythematosus
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 23, Pages: 278-281(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013230278
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
WANG Fu-zu, MA Hui-zhong, ZHOU Chun-yan, et al. 37 Cases of Lupus 1 Number Decoction in the Treatment of Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 278-281.
DOI：

WANG Fu-zu, MA Hui-zhong, ZHOU Chun-yan, et al. 37 Cases of Lupus 1 Number Decoction in the Treatment of Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 278-281. DOI： 10.11653/syfj2013230278.

摘要

目的: 探讨狼疮I号方对系统性红斑狼疮（SLE）活动期患者疾病活动的影响。方法: 将74例患者随机按数字法分为观察组和对照组各37例。两组均给予常规激素治疗，并给予必要的对症、支持处理。观察组加用狼疮I号方，1剂/d，常规水煎分2次服用。疗程4个月。记录面部红斑、关节疼痛、发热等主症状评分，记录激素用量及系统性红斑狼疮疾病活动度评分（SLEDAI）评分，检测治疗前后血清IL-10，IL-12，β-抑制蛋白质-1（β-arrestinl）及血栓调节蛋白（sTM）水平。结果: 观察组疾病疗效总有效率达100%，优于对照组的83.8%（P<0.05）;治疗后2个月，两组激素用量均较治疗前降低（P<0.01），治疗后4个月，观察组激素用量少于对照组（P<0.01），治疗后观察组激素撤减量多于对照组（P<0.05）;治疗后观察组面部红斑、关节疼痛、发热等症状评分均低于对照组（P<0.01）;治疗后观察组血清IL-10明前下降，并低于对照组（P<0.01），观察组血清IL-12水平升高，并高于对照组（P<0.01）;治疗后观察组血清β-arrestinl水平高于对照组（P<0.01），观察组血清sTM水平低于对照组（P<0.01）。结论: 狼疮I号方能有效控制SLE患者病情活动，协助患者激素的撤减，提高了临床疗效。

Abstract

Objective: The effects of Lupus 1 number decoction on patients with systemic lupus erythematosus (SLE). Method: Seventy-four patients were randomly divided into observation group (n=37) and control group(n=37). Both groups were given conventional hormone and necessary management. Homemade Lupus 1 number decoction was added to observation group

1 dose each day

conventional decocting with water for 2 times

for 4 months. The main symptom scores of facial erythema

arthralgia

fever were recorded. Dosage of hormone and Systemic Lupus Erythematosus Disease Activity(SLEDAI) scores were recorded. Serum IL-10

serum IL-12

β-arrestinl and sTM level pretherapy and post-treatment were detected. Result: The total effective rate of observation group(100% ) was superior to control group(83.8% ) (P<0.05);after the treatment for 2 months

dosage of hormone of both groups were lower than before(P<0.01);after treatment for 4 months

dosage of hormone of observation group was lower than control group(P<0.01);Observation group of hormone withdrawal reduction than the control group after treatmen(P<0.05);after treatment

the main symptom scores of facial erythema

arthralgia

fever of observation group was lower than control group(P<0.01);after treatment the level of serum IL-10 of observation group has dramatic decline and was lower than control group (P<0.01);after treatment the level of serum IL-12 of observation group was risen and higher than control group(P<0.01);β-arrestinl of observation group was higher than control group (P<0.01);sTM level of observation group was lower than control group(P<0.01). Conclusion: Lupus1 number decoction could effective control the disease activity of patients with SLE

assist the hormone withdrawal of patients and improve the clinical curative effect.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Systemic Lupus Erythematosus as a Dominant Disease in Traditional Chinese Medicine

Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment

Effect of Qihuang Jianpi Zishen Granules on STAT3/mTOR Signaling Pathway in Patients with Systemic Lupus Erythematosus

Clinical Effect of Xijiao Dihuangtang Combined with Acupuncture on Treatment of Systemic Lupus Erythematosus with Syndrome of Intense Heat Toxin

Laws of Syndrome and Prescription in Yin Deficiency Syndrome of Systemic Lupus Erythematosus Based on Complex Network Analysis

Related Author

XU Yuan

ZHANG Xiaoxiao

XUE Ke

MO Mei

TAO Qingwen

CUI Yong

CHEN Yanyu

WANG Zihan

Related Institution

Japan Friendship Hospital

National Key Laboratory for The Innovation and Development of Modern TCM

China Association of Chinese Medicine

The First Affiliated Hospital of Anhui University of Chinese Medicine

Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰